Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0000899243-20-004522

Chairman sold 20,000 shares at $62.90 ($1,258,000)

  • Chairman acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

El-Hibri Fuad · Chairman

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-11 Exercise or conversion : show line 1 in the form +6,280 $25.62 $160,894 1,485,298 D
2020-02-11 Sale : show line 2 in the form −6,280 $62.90 $395,012 1,479,018 D
2020-02-12 Exercise or conversion : show line 3 in the form +13,720 $25.62 $351,506 1,492,738 D
2020-02-12 Sale : show line 4 in the form −13,720 $62.90 $862,988 1,479,018 D
Open-market sales · 20,000 sh · avg $62.90 · $1,258,000

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-02-11 Exercise or conversion : show line 5 in the form Employee Stock Options (Right to Buy) −6,280 57,038 D
2020-02-12 Exercise or conversion : show line 6 in the form Employee Stock Options (Right to Buy) −13,720 43,318 D
Loading xslF345X03/doc4.xml…